Sign In
Buy SYN
$0.91
+0.0050 (+0.556%)
At Close: Jan 27, 2023
Synthetic Biologics Provides Update on SYN-020 Intestinal Alkaline Phosphatase Phase 1 Single-Ascending Dose Clinical Trial
07:00am, Tuesday, 29'th Jun 2021
ROCKVILLE, Md., June 29, 2021 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company leveraging the microbiome to develop therapeutics designed to pre
Synthetic Biologics' (SYN) CEO Steven Shallcross on Q1 2021 Results - Earnings Call Transcript
08:03pm, Wednesday, 05'th May 2021
Synthetic Biologics' (SYN) CEO Steven Shallcross on Q1 2021 Results - Earnings Call Transcript
Synthetic Biologics to Report 2021 First Quarter Operational Highlights and Financial Results on May 5, 2021
07:00am, Wednesday, 28'th Apr 2021
ROCKVILLE, Md., April 28, 2021 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company leveraging the microbiome to develop therapeutics designed to preve
ROCKVILLE, Md., April 14, 2021 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company leveraging the microbiome to develop therapeutics designed to pre
Synthetic Biologics Announces First Six Participants Dosed in Phase 1a Clinical Trial of SYN-020 Intestinal Alkaline Phosphatase
07:00am, Thursday, 01'st Apr 2021
ROCKVILLE, Md., April 1, 2021 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company leveraging the microbiome to develop therapeutics designed to prev
SYN Stock Price Increased 29.72%: Why It Happened
06:57am, Saturday, 13'th Mar 2021
The stock price of Synthetic Biologics Inc (NYSEAMERICAN: SYN) increased by 29.72% yesterday. This is why it happened.
Synthetic Biologics, Inc's (SYN) CEO Steve Shallcross on Q4 2020 Results - Earnings Call Transcript
10:01pm, Thursday, 04'th Mar 2021
Synthetic Biologics, Inc's (SYN) CEO Steve Shallcross on Q4 2020 Results - Earnings Call Transcript
Synthetic Biologics: 6 Things for SYN Stock Investors to Know as the Biotech Skyrockets
11:12am, Tuesday, 05'th Jan 2021
Synthetic Biologics (SYN) stock is soaring higher on heavy trading Tuesday even without a lack of news concerning the company. The post Synthetic Biologics: 6 Things for SYN Stock Investors to Know as
Synthetic Biologics, Inc. (SYN) CEO Steven Shallcross on Q3 2020 Results - Earnings Call Transcript
07:34pm, Tuesday, 10'th Nov 2020
Synthetic Biologics, Inc. (SYN) CEO Steven Shallcross on Q3 2020 Results - Earnings Call Transcript
